Acanthosis nigricans in the setting of severe pulmonary disease exacerbated by COVID-19 infection
Kelsey E. Hirotsu, MD,
Audris Chiang, MD,
Eman Bahrani, MD,
Jeffrey M. Cloutier, MD, PhD,
Kerri E. Rieger, MD, PhD,
Bernice Y. Kwong, MD,
Maria Aleshin, MD
Affiliations
Kelsey E. Hirotsu, MD
Department of Dermatology, Stanford University School of Medicine, Stanford, California; Department of Dermatology, University of California San Diego, San Diego, California
Audris Chiang, MD
Department of Dermatology, Stanford University School of Medicine, Stanford, California
Eman Bahrani, MD
Department of Dermatology, Stanford University School of Medicine, Stanford, California; Department of Pathology, Stanford University School of Medicine, Stanford, California; Department of Dermatology, University of California San Francisco, San Francisco, California; Department of Pathology, University of California San Francisco, San Francisco, California
Jeffrey M. Cloutier, MD, PhD
Department of Dermatology, Stanford University School of Medicine, Stanford, California; Department of Pathology, Stanford University School of Medicine, Stanford, California; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas
Kerri E. Rieger, MD, PhD
Department of Dermatology, Stanford University School of Medicine, Stanford, California; Department of Pathology, Stanford University School of Medicine, Stanford, California
Bernice Y. Kwong, MD
Department of Dermatology, Stanford University School of Medicine, Stanford, California
Maria Aleshin, MD
Department of Dermatology, Stanford University School of Medicine, Stanford, California; Correspondence to: Maria Aleshin, MD, Department of Dermatology, Stanford University School of Medicine, 450 Broadway St, Pavilion C, MC 5334, Redwood City, CA 94063.